Strados Labs developed the first-of-its-kind, FDA approved Respiratory Management Solution, RESP™. This wearable monitor listens and captures breathing patterns and lung acoustics for clinicians in a non-invasive, non-intrusive, and wireless way that ensures patient compliance. At the end of 2020, Strados received 510K clearance from the Food and Drug Administration for RESP™ and was in search of an agency to help propel their messaging and brand forward, while creating thought leadership for its CEO, Nick Delmonico. The company engaged Inspire to create a strategic communications and marketing plan and execute on it to help attract investors, create brand awareness and drive leads.
Inspire gave Strados a distinct brand voice and messaging to effectively tell the company’s story. We redesigned the company website and investor deck, while conducting media outreach for the Company’s FDA clearance, CE Mark, RESP advancements, new partnerships, new board members and more. Inspire developed and deployed social media content, thought leadership pieces and videos, as well as email templates for HubSpot deployment. Inspire shot over 15 thought leader and testimonials videos with doctors, key stakeholders and the CEO.
The new attractive and interactive investor deck is receiving positive comments from investors, and the company’s message and ask is clear and concise. Inspire helped Strados establish a social footprint with an audience of more than 1,600 community members. Engagement increased steadily under Inspire’s direction and more than tripled in less than six months.
investor deck design & content
HubSpot integrated emails
social media campaigns